Canton Hathaway, LLC Vir Biotechnology, Inc. Transaction History

Canton Hathaway, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$21.19 - $40.01 $54,246 - $102,425	-2,560 Closed	0 $0
Q4 2021 Jan 06, 2022	BUY	$30.97 - $54.03 $79,283 - $138,316	2,560 New	2,560 $107,000
Q3 2020 Nov 09, 2020	SELL	$28.28 - $53.6 $236,986 - $449,168	-8,380 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$27.89 - $47.86 $233,718 - $401,066	8,380 New	8,380 $343,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

Stay updated on Canton Hathaway, LLC with notifications on news.